Stoke Therapeutics, Inc. (STOK)
NMS – Real Time Price. Currency in USD
33.36
+0.40 (1.21%)
Market open: Aug 12, 2026, 12:19 PM EDT
32.96
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
33.36
+0.40 (1.21%)
Market open: Aug 12, 2026, 12:19 PM EDT
32.96
0.00 (0.00%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $110.0M significantly exceed its total debt $2.7M, ensuring strong financial flexibility
Total current assets $322.5M exceed Total current liabilities $41.9M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-3,848.8x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$58.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 7.69 | 6.05 | 10 | |
| Quick ratio | 7.69 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 10 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | -3848.76 | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 12M | 9M | 37M | 184M | 28M |
| Gross Profit | 9M | 4M | 32M | 180M | 23M |
| Operating Income | -104M | -115M | -101M | -21M | -223M |
| Net Income | -101M | -105M | -89M | -7M | -208M |
| EBITDA | -101M | -110M | -97M | -16M | -219M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -27.58 | -40.83 | 1.0 |
| Next quarter | 448.17 | -0.98 | 5.5 |
| Current year | -83.2 | -2916.03 | 1.0 |
| Next year | 31.9 | 2.64 | 7.0 |
| Weighted average score | 3.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 49.7 | -23.22 | -17.71 | 3.9 | 4.0 |
| Y/Y | -32.5 | -162.38 | -132.49 | -128.96 | 1.0 |
| 3y average | 230.54 | 34.56 | 43.95 | 5.18 | 8.8 |
| 5y average | 537.93 | 4.34 | 14.15 | 1.24 | 6.3 |
| Weighted average score | 5.0 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |